EFPIA Newsletter 04 September 2025

News     21 August 2025 EFPIA responds to the publication of the U.S.-EU Joint Framework Agreement EFPIA acknowledges the U.S.-EU Joint Framework Agreement published today by the European Commission and the U.S. Administration.... Read more →

Vaccines Europe Annual Report 2024 is now available The Vaccines Europe Annual Report 2024 showcases last year’s key achievements, from investing in prevention and driving innovation to strengthening supply chains and advancing HTA. Read the report here.

Events     22 SEP 2025   EFPIA Life Sciences Week Brussels A series of high-level policy discussions on the future of healthcare and innovation in Europe. Learn more →       01 OCT 2025   POLITICO Competitive Europe Summit Brussels, Belgium Competitiveness isn’t just a regional concern—it is a race to be ahead in the global pecking order. With China and the... Learn more →

	07 OCT 2025			Health Economics and Policy Evaluation Course October 2025 - ONLINE Online Join the Health Economics and Policy Evaluation  ONLINE Course 2025, delivered by the University of Oxford. This intensive... Learn more →

	04 NOV 2025			IHI Brokerage Event 2025 Brussels, Belgium If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and... Learn more →

What we are reading BMS’ Emma Charles on access, impact and inclusion 03 September 2025  (European Medical Journal) Read more → Ground-breaking international study on Lp(a) testing cost effectiveness 20 August 2025  (FH Europe Foundation) Read more → The world needs more than drugs to fight obesity, writes Novo Nordisk’s ex-boss 11 August 2025  (The Economist) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe